Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect MSCs Derived From the Placenta and Their Secretome for the Treatment of GvHD: A Randomized Clinical Trial

NCT06469411 is registered in ClinicalTrials.gov with Tabriz University of Medical Sciences as lead sponsor.

NCT NCT06469411
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06469411 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect MSCs Derived From the Placenta and Their Secretome for the Treatment of GvHD: A Randomized Clinical Trial
Lead sponsor
Tabriz University of Medical Sciences
Phase
Phase 3
Overall status
Completed
Start date
January 1, 2023
Completion date
January 30, 2024
Enrollment
60 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

gvhd